Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate versus artesunate plus azithromycin for uncomplicated falciparum malaria in central Vietnam
ACTRN12610000546055Phase 2Recruiting
- Sponsor
- Australian Defence Force Malaria and Infectious Disease Institute
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of artesunate and azithromycin in malaria and Falciparum malaria (PF) (2 arms), sponsored by Australian Defence Force Malaria and Infectious Disease Institute. Primary endpoints: Therapeutic efficacy and parasite clearance and Tolerability. Started May 2010; status: recruiting.
02
Drugs
artesunateazithromycin
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12610000546055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000546055.